BRAF and thyroid gland carcinoma: In this study, to better understand the molecular processes involved in BRAF inhibitors drug response, we investigated in vitro the two BRAF inhibitors Vemurafenib and Dabrafenib on BRAFV600E mutated thyroid cancer cell lines.